ATE299885T1 - Polynukleotide mit gekürzter kette und verfahren zu ihrer herstellung - Google Patents

Polynukleotide mit gekürzter kette und verfahren zu ihrer herstellung

Info

Publication number
ATE299885T1
ATE299885T1 AT00902934T AT00902934T ATE299885T1 AT E299885 T1 ATE299885 T1 AT E299885T1 AT 00902934 T AT00902934 T AT 00902934T AT 00902934 T AT00902934 T AT 00902934T AT E299885 T1 ATE299885 T1 AT E299885T1
Authority
AT
Austria
Prior art keywords
production
short chain
chain polynucleotides
same
polynucleotides
Prior art date
Application number
AT00902934T
Other languages
English (en)
Inventor
Shinji Matsuyama
Kouichi Ishiyama
Junzo Seki
Tadaaki Ohgi
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE299885T1 publication Critical patent/ATE299885T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/7125—Nucleic acids or oligonucleotides having modified internucleoside linkage, i.e. other than 3'-5' phosphodiesters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00902934T 1999-02-15 2000-02-14 Polynukleotide mit gekürzter kette und verfahren zu ihrer herstellung ATE299885T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3596399 1999-02-15
PCT/JP2000/000778 WO2000047601A1 (fr) 1999-02-15 2000-02-14 Polynucleotides a chaine raccourcie et procede de preparation correspondant

Publications (1)

Publication Number Publication Date
ATE299885T1 true ATE299885T1 (de) 2005-08-15

Family

ID=12456623

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00902934T ATE299885T1 (de) 1999-02-15 2000-02-14 Polynukleotide mit gekürzter kette und verfahren zu ihrer herstellung

Country Status (14)

Country Link
US (2) US6780429B1 (de)
EP (1) EP1153931B1 (de)
KR (1) KR100455814B1 (de)
CN (1) CN1194002C (de)
AT (1) ATE299885T1 (de)
AU (1) AU2460900A (de)
BR (1) BR0008227A (de)
CA (1) CA2359674A1 (de)
DE (1) DE60021354T2 (de)
ID (1) ID29546A (de)
NO (1) NO20013941D0 (de)
RU (1) RU2238279C2 (de)
WO (1) WO2000047601A1 (de)
ZA (1) ZA200106701B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010053763A1 (en) * 1998-12-02 2001-12-20 Andrew Salzman Method and composition for modulating an immune response
US6958324B2 (en) 1998-12-02 2005-10-25 Inotek Pharmaceuticals Corporation Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
US20060166315A1 (en) * 2002-12-26 2006-07-27 Masatoshi Murai Process for producing pnpase
WO2006054129A1 (en) * 2004-11-19 2006-05-26 Institut Gustave Roussy Improved treatment of cancer by double-stranded rna
US20110076296A1 (en) 2008-04-25 2011-03-31 Innate Pharma S.A. TLR3 Agonist Compositions
EP2116602A1 (de) 2008-05-07 2009-11-11 Institut Gustave Roussy Kombinationsprodukte zur Behandlung von Krebs
CN101352422B (zh) * 2008-09-17 2011-04-20 厦门朝阳生物工程有限公司 河豚毒素冻干粉针制剂及其制备方法
US20130195919A1 (en) 2010-03-05 2013-08-01 President And Fellows Of Harvard College Induced dendritic cell compositions and uses thereof
WO2012088272A1 (en) 2010-12-21 2012-06-28 Duke University Methods and compositions combining immunotherapy with monocyte activation
JP6257607B2 (ja) 2012-06-08 2018-01-10 アデュロ バイオテック，インコーポレイテッド 癌免疫療法のための組成物および方法
EP2930180B1 (de) * 2012-12-06 2021-11-10 Kyowa Hakko Bio Co., Ltd. Doppelsträngige ribonukleinsäure zur adjuvantien
AU2013358892B2 (en) 2012-12-13 2018-06-21 Aduro Biotech, Inc. Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
TN2015000457A1 (en) 2013-04-29 2017-04-06 Memorial Sloan Kettering Cancer Center Compositions and methods for altering second messenger signaling
US20140329889A1 (en) 2013-05-03 2014-11-06 The Regents Of The University Of California Cyclic di-nucleotide induction of type i interferon
AU2014268836B2 (en) 2013-05-18 2018-08-02 Aduro Biotech, Inc. Compositions and methods for activating "stimulator of interferon gene"-dependent signalling
US9549944B2 (en) 2013-05-18 2017-01-24 Aduro Biotech, Inc. Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
WO2015017652A1 (en) 2013-07-31 2015-02-05 Memorial Sloan-Kettering Cancer Center Sting crystals and modulators
WO2018112407A1 (en) 2016-12-15 2018-06-21 Duke University Antibodies and methods for depleting regulatory b10 cells and use in combination with immune checkpoint inhibitors
TW202308629A (zh) 2021-04-28 2023-03-01 法商Ｅｎｙｏ製藥公司 使用fxr激動劑作為組合治療以增強tlr3激動劑之療效

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692899A (en) * 1969-12-17 1972-09-19 Us Health Education & Welfare Inhibition of transplanted tumor growth by polyinosinic-polycytidylic acid in mice
US3666646A (en) * 1970-05-15 1972-05-30 Merck & Co Inc Reduction of molecular weight in polynucleotides using ultrasonic radiation
US5298614A (en) * 1986-01-06 1994-03-29 Nippon Shinyaku Co. Ltd. Size limited double stranded poly I poly(cytidylate/4-thiouridylate)
GB2207138B (en) * 1987-07-03 1992-02-05 Nippon Shinyaku Co Ltd Preparation of nucleic acid derivatives.
CA2156289C (en) * 1993-02-19 2006-01-03 Junichi Yano Drug composition containing nucleic acid copolymer
US5795587A (en) * 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US5886165A (en) * 1996-09-24 1999-03-23 Hybridon, Inc. Mixed backbone antisense oligonucleotides containing 2'-5'-ribonucleotide- and 3'-5'-deoxyribonucleotides segments

Also Published As

Publication number Publication date
ID29546A (id) 2001-09-06
RU2238279C2 (ru) 2004-10-20
CA2359674A1 (en) 2000-08-17
CN1340055A (zh) 2002-03-13
KR20020013500A (ko) 2002-02-20
NO20013941L (no) 2001-08-14
AU2460900A (en) 2000-08-29
US7223857B2 (en) 2007-05-29
EP1153931B1 (de) 2005-07-20
WO2000047601A1 (fr) 2000-08-17
KR100455814B1 (ko) 2004-11-06
CN1194002C (zh) 2005-03-23
DE60021354T2 (de) 2006-04-27
NO20013941D0 (no) 2001-08-14
BR0008227A (pt) 2001-10-30
DE60021354D1 (de) 2005-08-25
ZA200106701B (en) 2002-11-14
US6780429B1 (en) 2004-08-24
EP1153931A1 (de) 2001-11-14
US20040235044A1 (en) 2004-11-25
EP1153931A4 (de) 2002-07-17

Similar Documents

Publication Publication Date Title
ATE299885T1 (de) Polynukleotide mit gekürzter kette und verfahren zu ihrer herstellung
DE69813523T2 (de) Polyalkoxysiloxanverbindungen,verfahren zur herstellung und diese verbindungen enthaltende beschichtungszusammensetzungen
DE3781353D1 (de) Schlagzaehe polymere zusammensetzungen und verfahren zu ihrer herstellung.
DE68904986T2 (de) Verfahren zur herstellung von 1,1,1-trifluor-2,2-dichlorethan.
ATE186728T1 (de) Imidazochinoxalinone, ihre azaanaloge und verfahren zu ihrer herstellung
DE69230967T2 (de) Verfahren zur herstellung von 2,6-naphthalindicarbonsäure
DE68907320D1 (de) Verfahren zur herstellung von modifizierten polypropylen-zusammensetzungen.
DE69909003D1 (de) Verfahren zur Herstellung von Polyamiden
ATE388135T1 (de) Verfahren zur herstellung von 1,3-substituierte indene und aryl-annellierte azapolycyclische verbindungen
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE69800805T2 (de) Verfahren zur herstellung chiraler 3,4-epoxybuttersäure und ihrer salze
DE68916035D1 (de) Verfahren zur selektiven herstellung von 2,6-dialkylnaphthalenen.
DE69901519D1 (de) Verfahren zur Herstellung von 2,2'-bis (Hydroxymethyl)alkansäure
DE59006645D1 (de) Verfahren zur kontinuierlichen herstellung von 3,3'-dichlor-benzidin-dihidrochlorid.
DE3768426D1 (de) Verfahren zur herstellung von 4,4'-biphenyldicarbonsaeure.
DE50006245D1 (de) Verfahren zur herstellung von (1,1':4',1'')-terphenylvebindungen
DE59804673D1 (de) Verfahren zur herstellung von vinylphosphonsäure-verbindungen
ATE125700T1 (de) Ibuprofen- und s-(+)-ibuprofen zubereitungen und verfahren zu ihrer herstellung.
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen
DE69510798T2 (de) Verfahren zur herstellung von kalziumsalzen von [s,s]-äthylendiamin- n,n'-dibernsteinsäure
DE3781095D1 (de) Calciumhypochloritzusammensetzungen und verfahren zu ihrer herstellung.
DE59801815D1 (de) Verfahren zur herstellung von 1,2-dichlorethan durch oxichlorierung
DE69815393D1 (de) Verfahren zur kontinuierlichen herstellung von kaugummi
DE3781868D1 (de) Copolyamid und verfahren zu dessen herstellung.
ATE249453T1 (de) Verfahren zur herstellung von tricyclischen verbindungen mit antihistaminischer wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties